U.S. Markets close in 2 hrs 51 mins

Why Analysts Reduced Target Price of Immunomedics

Margaret Patrick
Why Analysts Reduced Target Price of Immunomedics

How These Biotechnology Stocks Are Positioned in March(Continued from Prior Part)Analysts’ recommendations and target price Wall Street analysts expect an upside potential of 25.69% for Immunomedics (IMMU) based on the company’s closing price on